Trastuzumab deruxtecan: An antibody-drug conjugates for non-small cell lung cancer
Journal of Oncology Pharmacy Practice
Published online on October 01, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
ObjectivesThis review compiles to provide an overview of non-small cell lung cancer (NSCLC) and the therapeutic rationale for antibody-drug conjugates (ADCs), followed by a summary of current evidence highlighting the efficacy, safety, and adverse event ...
ObjectivesThis review compiles to provide an overview of non-small cell lung cancer (NSCLC) and the therapeutic rationale for antibody-drug conjugates (ADCs), followed by a summary of current evidence highlighting the efficacy, safety, and adverse event ...